The role of dietary and other lifestyle factors in colorectal cancer recurrence and survival is largely unknown. We conducted a review to summarize the evidence from epidemiologic studies that examined the association of body mass index (BMI), physical activity, and nutrition with colorectal cancer recurrence and survival. We searched MEDLINE and EMBASE for relevant epidemiologic studies published up to March 2010 by using MeSH terms and related key words. We identified 36 articles that were based on 31 independent studies on BMI (n ¼ 21), physical activity (n ¼ 6), or nutrition (n ¼ 12) in relation to colorectal cancer recurrence and survival. Studies were generally based on follow-up of cases in existing patient series, case-control or cohort studies, or chemotherapy trials. BMI, physical activity, and nutrition mostly referred to the time at or before diagnosis. Only 10 studies assessed BMI (n ¼ 1), physical activity (n ¼ 4), or nutrition (n ¼ 5) after diagnosis. There may be an association between higher BMI and body fatness before or at the time of diagnosis and a higher all-cause mortality or colorectal cancer-specific mortality or recurrence, although results may differ by sex, tumor location, and molecular subtype. There may be a relation between higher leisure-time physical activity after diagnosis and a lower all-cause or colorectal cancer-specific mortality. For dietary factors, statistically significant associations were only shown for single foods, nutrients, and dietary patterns in single studies. In conclusion, only a paucity of data is available on the effect of dietary and other lifestyle factors on colorectal cancer recurrence and survival. Thus far, no clear conclusions can be drawn. Future studies are warranted, particularly on postdiagnosis BMI and diet.
INTRODUCTION
Colorectal cancer is the third most common cancer worldwide (1) . The number of patients who survive colorectal cancer is increasing, partly because of earlier detection and more-effective treatment methods. The age-adjusted 5-y relative survival rate over the period 1988-1999 increased from 48% to 54% in Europe (2) , and a period analysis over 2000 to 2002 showed an age-adjusted 5-y relative survival rate of 56% for Europe and 66% for the United States (3) . Worldwide, colon and rectum cancers accounted for '1 million new cases in 2002, and an estimated 2.8 million persons diagnosed with colorectal cancer were alive 5 y of diagnosis (1) .
After diagnosis, individuals with colorectal cancer remain at an increased risk of colorectal cancer recurrence, secondary cancer, other chronic diseases, and cancer death. Their clinical outcome is dependent on several tumor characteristics, such as tumor stage, grade, lymph node involvement, and metastases (4) . Also, differences in methods of treatment influence the cancer prognosis. However, there is still a large variability in the clinical outcome of individuals with morphologic identical colorectal cancers who receive comparable therapeutic strategies. This variability may be due to differences in nutritional or other lifestyle factors.
Dietary and lifestyle factors in relation to colorectal cancer incidence have been extensively investigated. The second World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) expert report (5) showed that higher body fatness, abdominal fatness, adult attained height, red meat and processed-meat intake, and lower physical activity are associated with a higher colorectal cancer risk. Higher alcohol intake is associated with a higher colorectal cancer risk in men, and probably also in women. Higher dietary fiber, garlic, milk, and calcium intakes are probably associated with a lower colorectal cancer risk. Further, there is limited suggestive evidence for a protective effect of nonstarchy vegetables, fruit, fish, and foods that contain folate, vitamin D, or selenium. In contrast, higher intake of cheese and foods containing iron, animal fats, or sugars may lower colorectal cancer risk.
Compared with the vast amount of literature with respect to colorectal cancer incidence, there is only a paucity of data about the effect of dietary and lifestyle factors on colorectal cancer recurrence and survival. This information is important because many individuals who have been diagnosed with colorectal cancer are motivated and have been shown to adjust their dietary and physical activity patterns (6) (7) (8) . This review will summarize the evidence for the role of body mass index (BMI; in kg/m 2 ), physical activity, and diet before, at the time of, and after co-lorectal cancer diagnosis in colorectal cancer recurrence and survival.
METHODS
A search in the MEDLINE (www.ncbi.nlm.nih.gov/pubmed) and EMBASE (www.embase.com) databases was conducted up to March 2010 by using a combination of MeSH terms (colorectal neoplasms, recurrence, disease-free survival, mortality, motor activity, body weight, BMI, waist circumference, waist-hip ratio, body fat distribution, diet, diet therapy, food and beverages, and nutritional sciences) and related key words in titles or abstracts. Retrieved references were checked independently by the 2 investigators, and discordances were discussed and resolved. Relevant articles were obtained and included in the review if they reported on epidemiologic studies in colorectal cancer survivors with respect to BMI, physical activity, or diet in relation to allcause mortality, colorectal cancer-specific mortality, or colorectal cancer recurrence. Reference lists of relevant articles were checked to identify any additional epidemiologic studies. Only articles written in the English language were included. Studies were excluded from this review if they solely investigated associations of BMI, physical activity, or diet with intermediate endpoints of disease or with tumor characteristics and not with allcause mortality, colorectal cancer-specific mortality, or colorectal cancer recurrence. Weight loss and underweight were not taken into consideration because these factors are more likely to be of a disease-related cause than a lifestyle-related cause of disease outcome. Information extracted from each study included the first author, year, country, sample (size and key characteristics), followup time, variable of interest, assessment method, outcome, contrast, risk estimates with 95% CIs, and factors that were adjusted for in the analysis.
Because of the relatively small number of relevant studies and the large heterogeneity in type of exposure, timing of exposure assessment, and disease outcomes, a formal meta-analysis could not be conducted. The studies on BMI, physical activity, or diet in relation to all-cause mortality, colorectal cancer-specific mortality, or colorectal cancer recurrence were described separately according to the time period these factors were assessed [ie, before diagnosis (prediagnosis), at diagnosis, or after diagnosis (postdiagnosis)].
RESULTS
The initial search retrieved 2801 articles. We identified a total of 36 relevant articles that were based on 31 independent epidemiologic studies in colorectal cancer survivors that reported on BMI, physical activity, or dietary factors in relation to all-cause mortality, colorectal cancer-specific mortality, or colorectal cancer recurrence ( Figure 1 ). These studies are discussed in more detail in this review.
BMI
The association between BMI and recurrence or survival of colorectal cancer has been investigated in 21 observational studies described in 24 articles (9-32) ( Table 1) . Six studies evaluated BMI before diagnosis (9-16), 14 studies investigated BMI at diagnosis (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) , and one study focused on BMI during and after chemotherapy (32) . Nine studies investigated selfreported BMI (9, 10, 13-18, 22, 28, 32) , 7 studies evaluated measured BMI (11, 12, 19-21, 24, 25) , and 4 studies obtained BMI from medical records (23, 26, 27, 29, 31) . One study did not provide any information about BMI assessment (30) . Some studies additionally reported on measured body weight (12, 17) , waist circumference (12), percentage body fat (12) , and visceral and subcutaneous fat areas (24, 30) .
BMI before cancer diagnosis
Prediagnosis BMI and all-cause or cancer-specific mortality was investigated by 6 studies that were based on existing casecontrol (9, 10) or cohort studies (11) (12) (13) (14) (15) (16) that were originally designed to investigate dietary and lifestyle factors in relation to cancer incidence. Except for one study (11) , all other studies were adjusted for the tumor stage. In 3 studies, including 410 colon cancer cases (9), 1882 colorectal cancer cases (11) , and 526 colorectal cancer cases (12) , no association of higher BMI with all-cause mortality (9, 11, 12) or colorectal cancer-specific mortality (12) was observed. Higher body fat, weight, and waist circumference were associated with a higher colorectal cancerspecific mortality but not with all-cause mortality (12) . One study in 633 colorectal cancer cases reported a higher risk of colon cancer-specific mortality [hazard ratio (HR): 2.1: 95% CI: 1.1, 3.8] and all-cause mortality (HR: 1.5: 95% CI: 1.0, 2.1) in obese compared with normal weight postmenopausal women (10) . The risk of rectal cancer-specific mortality was not increased, and no association in overweight women was shown (10) . Two studies in 647 colon cancer cases (13) (14) (15) and 546 colorectal cancer cases (16) , respectively, showed that the association between prediagnosis BMI and cancer-specific or allcause mortality may depend on molecular characteristics of the tumor. Higher BMI was associated with higher all-cause mortality in individuals with tumors positive for fatty acid synthase expression (13), p27 (cyclin-dependent kinase inhibitor 1B) expression (14) , p21 (cyclin-dependent kinase inhibitor 1A) expression (15) , or stathmin or oncoprotein-18 expression (16) . The association between higher BMI and higher cancer-specific mortality only reached statistical significance for individuals with tumors positive for p21 expression (15) and stathmin or oncoprotein-18 expression (16). 
BMI at cancer diagnosis
Fourteen studies investigated BMI at the time of colorectal cancer diagnosis (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . The first study on BMI in relation to colon cancer recurrence was published in 1984 and conducted in 279 consecutively diagnosed colon cancer patients who were undergoing curative resection (17) . This study showed a higher risk of recurrence in women but not in men above compared with below the median BMI and did not adjust for any other relevant factors. One study that was based on an existing casecontrol study that included 148 colorectal cancer patients showed no relation between BMI at diagnosis and 5 or 10 y of survival (18) . In a study initially set up as a case-case study, higher BMI was associated with lower all-cause mortality in 358 sporadic colorectal cancer cases but not in 141 familial colorectal cancer cases (22) . One study conducted in Iran was reported twice (23, 26) and first showed analyses for colorectal cancer patients combined (23) and later showed analyses for colon and rectal cancer cases, separately (26) . Although the follow-up time for the colon and rectal cancer cases was somewhat longer than for the colorectal cancer cases combined, the number of colon and rectal cases included in the analyses was lower than the number of colorectal cancer cases, partly because of differential adjustment for confounding factors. Overweight and obesity were nonstatistically significantly associated with higher all-cause mortality in colorectal cancer cases combined (23) . All-cause mortality was significantly lower in overweight and nonsignificantly lower in obese colon and rectal cancer cases separately compared with normal weight colon and rectal cancer cases (26) . In 39 colorectal cancer (25) and 230 rectal cancer patients (29) , overweight (25) and obesity (29) were not associated with all-cause mortality (25, 29) or recurrence (29) . No association for overweight was shown in 73 colorectal cancer patients with liver metastases (31) , whereas in another study in stage IV colon cancer patients, a protective effect on all-cause mortality was shown (27) . In a small study in 161 colorectal cancer patients, a high compared with low ratio of visceral fat and subcutaneous fat area was associated with a higher risk of recurrence or all-cause mortality (HR: 1.98; 95% CI: 1.02, 3.87), whereas no association for overweight was shown (24) . A recent study in 80 colorectal cancer patients who received a bevacizumab-based chemotherapeutic treatment confirmed that a visceral fat area above the median compared with below the median was associated with a higher risk of allcause mortality (HR: 2.88; 95% CI: 1.13, 7.32) (30) . No associations with the subcutaneous fat area and BMI were observed, and none of these 3 factors were associated with all-cause mortality in 40 colorectal cancer patients who received chemotherapy alone (30) . A study in 1873 rectal cancer patients reported a higher risk of local recurrence in obese compared with underweight patients with lower rectal cancer (HR: 4.71: 95% CI: 1.01, 21.9) but not in patients with upper rectal cancer (28) . No association of obesity with recurrence and death was observed for both patient groups (28) .
Three large adjuvant chemotherapy trials investigated BMI measured at day 1 of chemotherapy (19) (20) (21) in relation to cancer recurrence and survival in 3759 (19) and 4288 (21) patients with colon cancer and 1688 patients with rectal cancer (20) . Analyses were extensively adjusted for several prognostic variables, including the tumor stage, bowel obstruction at the time of surgery, and functional and physical performance status. In one study, obese women (BMI !30) were at a higher risk of all-cause mortality (HR: 1.34; 95% CI: 1.07, 1.67) and at a nonsignificantly higher risk of colon cancer recurrence (HR: 1.24; 95% CI: 0.98, 1.59) compared with normal weight women, particularly those ,50 y of age (HR: 2.58; 95% CI 1.23, 5.42 for colon cancer recurrence) (19) . No such associations were observed in men (19) . In the other study, only severe obesity (BMI !35) compared with normal weight was associated with a higher risk of recurrence (HR: 1.38; 95% CI: 1.10, 1.73), colon cancer-specific mortality (HR: 1.36; 95% CI: 1.06, 1.73), and all-cause mortality (HR: 1.28; 95% CI: 1.04, 1.57), and similar results were obtained for men and women (21) . In patients with rectal cancer, obese men (BMI !30) were at higher risk of local rectal cancer recurrence compared with normal weight men (HR: 1.61; 95% CI: 1.00, 2.59) (20) . The risk of all-cause mortality was not increased, and no significant associations were observed in women. Local rectal cancer recurrence was also higher in overweight men (BMI of 25-26.9: HR: 1.66; 95% CI: 1.07, 2.56). Further, no significant associations with overweight were shown in these studies.
BMI after cancer diagnosis
Only one study investigated BMI during chemotherapy and weight change from the time of chemotherapy through 6 mo after completion of chemotherapy (32) . This study was conducted in 1053 patients with colon cancer. Obese (BMI of 30-34.9) or severely obese (BMI !35) subjects compared with normal weight subjects at the time of chemotherapy were not at higher risk of recurrence and/or all-cause mortality. Also, weight gain from the time of chemotherapy through 6 mo after chemotherapy was not associated with recurrence and/or death.
Physical activity
The association between physical activity and recurrence or survival of colorectal cancer was investigated in 6 studies (12, 18, 33-36) ( Table 2 ). In 4 of these studies, previously validated physical activity questionnaires were used, and leisure-time physical activity was assessed in metabolic equivalent task (MET)-hours per week (33) (34) (35) (36) . One study recorded physical activity as low (totally sedentary lifestyle), moderate, or high (recreational or occupational activity that required strenuous physical activity), but no further details were given (18) . In the other study, 3 questions were asked about the frequency per week of vigorous exercise, less vigorous exercise, and walking (12) . There were no results of randomized clinical trials on physical activity and recurrence or survival of colorectal cancer.
Physical activity before cancer diagnosis
In 526 colorectal cancer patients who were identified within a cohort study, nonoccupational physical activity was assessed before diagnosis (12) . Exercisers were shown to be at lower risk of colorectal cancer-specific mortality than were nonexercisers (HR: 0.73; 95% CI: 0.54, 1.00). In another study in 573 female colorectal cancer patients, colorectal cancer-specific and allcause mortality did not differ for women in the highest quartile compared with the lowest quartile of leisure-time physical activity that was assessed a median of 6 mo before diagnosis (33) . Similarly, in 661 male colorectal cancer patients, no significant trend in colorectal cancer-specific and all-cause mortality was detected with increasing exercise (36) .
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Physical activity at time of cancer diagnosis
In a study in 148 colorectal cancer patients, physical activity assessed at 3 mo of diagnosis was not related to the 5-or 10-y survival of colorectal cancer (18) .
Physical activity after cancer diagnosis
In the study in 573 female colorectal cancer patients (33) , cases in the highest quartile for leisure-time physical activity that was assessed 1-4 y after diagnosis were at lower risk of colorectal cancer-specific mortality than were cases in the lowest quartile (HR: 0.39; 95% CI: 0.18, 0.82). Similar results were obtained in the 661 male colorectal cancer survivors (HR: 0.47; 95% CI: 0.24, 0.92) (36) . Risk estimates for all-cause mortality were comparable with those for colorectal cancerspecific mortality for both studies. Furthermore, female colorectal cancer patients who increased their physical-activity level after diagnosis were at lower risk of colorectal cancerspecific mortality (HR: 0.48; 95% CI: 0.24, 0.97) and all-cause mortality than were patients that did not change their physicalactivity level (33) . A randomized adjuvant chemotherapy trial in 832 colon cancer patients showed a lower risk of colon cancer recurrence or death for patients in the highest quintile of physical activity 6 mo after chemotherapy than for patients in the lowest quintile (HR: 0.55; 95% CI: 0.33, 0.91) (34) . Another study in 484 colon cancer patients showed a nonsignificantly lower risk of colon cancer-specific mortality (HR: 0.64: 95% CI: 0.33, 1.23) and a lower risk of all-cause mortality (HR: 0.60: 95% CI: 0.41, 0.86) for cases with a leisure-time physical activity of !18 MET-h/wk than cases who engaged in ,18 MET-h/wk of exercise after diagnosis (35) . This study also investigated whether this protective association was dependent on molecular characteristics of the tumor. The postdiagnosis leisure-time physical activity of !18 MET-h/wk compared with ,18 MET-h/wk decreased the risk of colon cancer-specific mortality for tumors with p27 nuclear expression (HR: 0.32; 95% CI: 0.12, 0.85) but not for tumors with a loss of p27. Physical activity did not differentially affect the all-cause mortality of p27-positive and p27-negative tumors. No modifying effect of fatty acid synthase, Kirsten rat sarcoma viral oncogene homolog; p53; p21; and phospoinositide-3-kinase, catalytic, alpha polypeptide on the association between exercise and colon cancer-specific or all-cause mortality was observed.
Dietary factors
The association between dietary factors and the recurrence or survival of colorectal cancer has been investigated in 12 observational studies described in 14 articles (9, 11, 18, 22, 25, 26, (37) (38) (39) (40) (41) (42) (43) (44) (Table 3) . Seven of these studies examined dietary factors that referred to the time before cancer diagnosis (9, 11, 18, 22, 26, (37) (38) (39) (40) , and 5 studies investigated postdiagnosis dietary factors (25, (41) (42) (43) (44) . Eight studies examined habitual diet assessed by a questionnaire (9, 11, 18, 22, 25, 26, 37, 38, 41) . These studies used food-frequency questionnaires (9, 22, 25, 37, 38, 41) or a qualitative and quantitative dietary questionnaire (18) or obtained information about alcohol intake from a baseline questionnaire (11) or hospital-document information (26) . Four studies evaluated blood concentrations of vitamins (39, 40, (42) (43) (44) . As also reported by the second WCRF/AICR expert report (5), only 5 small intervention studies conducted in 100 randomly assigned colorectal cancer patients investigated the effects of diet and supplements with respect to all-cause mortality, and no significant results were shown. A more recent flavonoid intervention in 29 colorectal cancer patients did not show any effect on cancer recurrence either (45) . The null results can be largely explained by small numbers and low trial quality, and are not further discussed in this review.
Dietary factors before cancer diagnosis
Six studies investigated prediagnosis diet and were initially set up as case-control (9, 18), case-case (22, 37), or cohort (11, 38) studies to examine the association between dietary factors and colorectal cancer incidence or were based on cancer-registry data (26) . Studies included 148 to 1882 colorectal cancer cases. Diet was assessed after a cancer diagnosis by a questionnaire that referred to habitual diet before the diagnosis (9, 18, 22, 26, 37) or interview (11, 38) . In all but one (11) studies, associations were adjusted for the tumor stage at the diagnosis, and associations in one study (22) were additionally adjusted for the cancer treatment. In 2 of the 3 studies, high compared with low energy intake before diagnosis was associated with a lower risk of allcause death at 2 (9) and 5 y (18) of survival, but no association was shown after longer follow-up. In the other study, prediagnosis energy intake was not associated with overall survival after 7-9 y of follow-up (22) . Higher dietary fiber intake was associated with a higher risk of all-cause mortality in one study (9) but not in the other 2 studies (18, 22) . In the case-case study, higher meat consumption was associated with a higher risk of all-cause mortality in familial but not sporadic colorectal cancer cases (37) . Further, regular compared with infrequent wine consumption was associated with a lower risk of all-cause mortality in cases with a family history of colorectal cancer only (22) . No association was shown for total alcohol consumption with all-cause mortality in 2 studies in colorectal (11) and colon (26) cancer cases, respectively. Whole-year daily use of cod liver oil or daily use of other dietary supplements compared with nonuse was also not associated with all-cause mortality in colorectal cancer cases (38) .
In a cohort study that included 304 colorectal cancer cases, plasma concentrations of 25-hydroxyvitamin D 3 [25(OH)D] (39) or folate (40) were evaluated. Plasma concentrations were assessed a median of 6 y before the colorectal cancer diagnosis and were related to colorectal cancer-specific and all-cause mortality. Both analyses were adjusted for the stage of disease, and in the analysis on folate, a limited adjustment for the use of chemotherapy was possible. Colorectal cancer-specific mortality was nonsignificantly lower for subjects in the highest quartile than in the lowest quartile of plasma 25(OH)D concentrations (HR: 0.61; 95% CI: 0.31, 1.19) and was significantly lower for the highest quintile than for the lowest quintile of plasma folate concentrations (HR: 0.42; 95% CI: 0.20, 0.88). Results were similar for all-cause mortality. 
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Dietary factors after cancer diagnosis
Postdiagnosis diet in relation to colorectal cancer recurrence and survival was reported by 2 studies (25, 41) . One study was a large postoperative adjuvant chemotherapy trial in 1009 stage-III colorectal cancer patients, and diet was assessed midway through therapy and 6 mo after completion of therapy. Analyses were extensively adjusted for several prognostic factors, including the tumor stage, clinical perforation, and bowel obstruction at the time of surgery. Subjects in the highest quartile compared with subjects in the lowest quartile of a Western dietary pattern, characterized by high intakes of meat, fat, refined grains, and dessert had a higher risk of all-cause mortality (HR: 2.32; 95% CI: 1.36, 3.96), recurrence (HR: 2.85; 95% CI: 1.75, 4.63), and recurrence and/or death (HR: 3.25; 95% CI: 2.04, 5.19) . No associations for a prudent dietary pattern, which was characterized by high intakes of fruit and vegetables, poultry, and fish, were observed. The other study was a very small study in 39 colorectal cancer patients, and no association was observed for low compared with high energy or protein intake during the week 3 after diagnosis with 1 y of survival (25) .
One study investigated plasma concentrations of antioxidants before potentially curative resection or chemotherapy and/or supportive care (42) . This study included 53 patients with primary operable colorectal cancer and 53 patients with unresectable liver metastases. Patients with unresectable liver metastases with plasma retinol concentrations above the median were shown to have a lower colorectal cancer-specific mortality than patients whose plasma retinol concentrations were below the median. No associations were observed for a-tocopherol, lutein, lycopene, a-carotene, and b-carotene plasma concentrations, and no associations were reported for patients with primary operable colorectal cancer. In another study in 93 colorectal cancer patients with unresectable metastases, patients with serum cobalamin concentrations below the median had a lower risk of all-cause mortality than did patients with serum cobalamin concentrations above the median (43) . Folate concentrations were not associated with all-cause mortality in this study. One large cohort study, including 1017 colorectal cancer cases, observed a lower risk with higher predicted 25(OH)D concentrations for colorectal cancer-specific mortality (HR: 0.50; 95% CI: 0.26, 0.95) and all-cause mortality (HR: 0.62; 95% CI: 0.42, 0.93) (44) .
DISCUSSION
This review shows that there is a paucity of published studies on BMI, physical activity, and dietary factors in relation to colorectal cancer recurrence and survival. Because of these small numbers and the large heterogeneity in the type of exposure, timing of exposure assessment, and disease outcomes investigated, summarizing the results and drawing firm conclusions is difficult. Higher BMI or body fatness before or at time of diagnosis may be associated with higher all-cause mortality, colorectal cancer-specific mortality, or recurrence, although results appeared to differ according to sex, tumor location, and the molecular subtype of the tumor. There is suggestive evidence that a higher postdiagnosis leisure-time physical activity is associated with lower all-cause and colorectal cancer-specific mortality. Further, dietary factors might be associated with allcause mortality, colorectal cancer-specific mortality, or recurrence, but significant associations were only shown for single foods, nutrients, and dietary patterns in single studies.
Different study designs have been used to investigate the association of BMI, dietary factors, and physical activity with colorectal cancer recurrence and survival. Studies were based on the follow-up of colorectal cancer patients who were either part of a patient series, existing case-control, case-case, and cohort studies, or randomized adjuvant chemotherapy trials. As previously discussed by Kushi et al (46) , such cancer-survival studies are very cost-effective because already collected data can be used. However, a general limitation of these studies is that they are specifically designed to examine the colorectal cancer risk rather than colorectal cancer recurrence and survival.
In studies based on existing case-control studies, dietary and other lifestyle factors are assessed after diagnosis and generally refer to the time before or the time at diagnosis. These studies may be prone to recall bias, with the implication that cases may report differently depending on their health status, their ability to eat and to be physically active, and their beliefs about cancer causes. Further, prediagnosis exercise and diet may actually be reflective of postdiagnosis exercise and diet. Selection bias may also have occurred because only survivors of colorectal cancer were included in these studies.
The advantage of studies that are based on existing cohort studies conducted in healthy individuals is that they are not subject to recall bias. However, a limitation is that, for each individual, the cancer is diagnosed at a different time point during the follow-up time of the study. Thereby, the time between data collection and cancer diagnosis is not identical for all colorectal cancer survivors. Further, in existing cohort studies as well as in case-control studies, therapeutic data are mostly not collected, and the patient population is very heterogeneous and includes all stages of disease.
In contrast, in studies based on randomized chemotherapy trials, treatment and follow-up care is standardized, and homogeneous disease stages are included. A prospective evaluation of dietary and other lifestyle factors and evaluation of changes in these factors that may occur after patients completed adjuvant chemotherapy and recovered from treatment effects are possible. Information on disease-and therapy-related factors is also available, although adjustment for these factors may not substantially change the crude-risk estimates (19, 20, 41) . Disadvantages of therapeutic trials are that patients may differ from the population at large, and postdiagnosis physical activity and diet may be reflective of prediagnosis physical activity and diet, which are not assessed.
The findings of an higher risk of all-cause mortality, colorectal cancer-specific mortality, or recurrence with higher BMI or body fatness before (10, (12) (13) (14) (15) (16) or at the time of diagnosis (17, 19-21, 24, 28, 30) and lower leisure-time physical activity after diagnosis (33) (34) (35) (36) are in agreement with the epidemiologic evidence on colorectal cancer development (5). The elevated risks for higher BMI are not likely to be due to the chemotherapy underdosing of obese patients (19) (20) (21) . Rather, as in colorectal cancer risk, the risks may be mediated by a higher insulin resistance and higher concentrations of insulin and insulin-like growth factor I, which promote cell proliferation and inhibit apoptosis (47, 48) . Higher physical activity may lower colorectal cancer recurrence and mortality risk by similar, but opposed, mechanisms. For the dietary factors, only the association of higher prediagnosis plasma concentrations of 25(OH)D and folate with lower colorectal cancer-specific mortality (39, 40, 44) was in line with the suggestive protective effect of foods that contain vitamin D or folate on primary colorectal cancer risk (5) .
Although the recommendations on physical activity and nutrition are met by only a small proportion of colorectal cancer survivors (49) (50) (51) (52) , the subjects appear to have a strong interest in making changes in dietary and other lifestyle factors after the diagnosis of cancer (6) (7) (8) . To our knowledge, there is no substantial evidence that changes in diet or lifestyle after diagnosis affect colorectal cancer recurrence and survival.
Thus, the important question that remains concerns what type of studies are needed to gain more insight in the role of dietary and other lifestyle factors in colorectal cancer recurrence and survival. First, in line with what is already being done for breast survivors (53) (54) (55) (56) , it is of vital importance to set up new prospective cohort studies of colorectal cancer survivors. Considerations for the design of such studies have been discussed by Kushi et al (46) . In brief, colorectal cancer cases should be rapidly ascertained so they can be enrolled soon after the diagnosis of cancer. Dietary and lifestyle factors should be assessed at critical points in time (eg, at the diagnosis and before, during, and after treatment of colorectal cancer). Colorectal cancer cases should be clearly defined with respect to the tumor location and tumor stage. Blood samples or tissue samples of the primary colorectal tumor should be collected and stored for further investigation of genetic factors and biomarkers. Data on cancer treatment, supplement use, and other potential prognostic factors should also be routinely collected. Studies should be able to stratify by sex and tumor location because these may be potential effect modifiers. Further, it is important to assess markers of abdominal fatness, such as waist and hip circumference, in addition to body weight, on the basis of the positive associations shown in 2 previous colorectal cancer-survivor studies (12, 24) .
Second, on the basis of the outcomes of these cohort studies, randomized trials to investigate the causal relation between dietary and other lifestyle factors with colorectal cancer recurrence and survival should be initiated. Recently, 4 study protocols and one feasibility study of randomized trials were published that aim to investigate the effects of physical activity or a lifestyle intervention in colorectal cancer survivors (57) (58) (59) (60) (61) . Two of these studies address colorectal cancer recurrence or mortality (58, 59) . The Colon Health and Life-Long Exercise Change trial is set up to establish the effect of a 3-y behavioral support program and supervised physical activity sessions on disease-free survival in 962 colon cancer survivors (58) . LiveWell is a 3-mo personalized lifestyle program for colorectal survivors (59) , and a feasibility study in 18 survivors showed that such a lifestyle intervention is feasible and should be personalized to suit abilities, provide feedback on personal goals, and encourage social support (59) .
In conclusion, a paucity of studies on the effect of dietary and other lifestyle factors in relation to colorectal cancer recurrence and survival is available, with large heterogeneity in the type of exposure, timing of exposure assessment, and disease outcomes. Although some studies suggest that higher BMI before or at the time of diagnosis and lower leisure-time physical activity after diagnosis may be related to a higher risk of colorectal cancerspecific recurrence and mortality, no firm conclusions can be drawn. New observational studies and randomized trials in colorectal cancer survivors are warranted. These studies should especially address the effect of BMI and diet after diagnosis. Until new evidence becomes available, colorectal cancer survivors are advised to follow the WCRF/AICR dietary recommendations for cancer prevention (5). An error was identified in the 24-h urinary excretion of total resveratrol metabolites, which was incorrect at baseline and after 3 interventions. The statistical analysis between interventions has now been updated. The aim of this measure was to provide intervention compliance through the calculation of the biomarker of wine consumption. This has been previously defined as the sum of 7 phase II metabolites of resveratrol specified in reference 31. These metabolites are as follows: trans-and cis-resveratrol-3-O-glucuronide, cis-resveratrol-4#-O-glucuronide, trans-and cis-resveratrol-4#-O-sulfate, and trans-and cisresveratrol-3-O-sulfate.
On page 328, the first sentence of the left-hand column of the Methods section should read as follows: ''Resveratrol conjugates derived from phase II metabolism were measured in 24-h urine samples by using the validated methodology described by Urpi-Sarda et al (30) quantitatively adapted due to the commercial and available standards. trans-and cis-Resveratrol-3-Oglucuronide (98% purity each), cis-resveratrol-4#-O-glucuronide (96% purity), and trans-resveratrol-3-O-sulfate (98% purity) were purchased from Toronto Research Chemicals Inc. trans-and cis-Resveratrol-4#-O-sulfate and cis-resveratrol-3-O-sulfate were quantified using the trans-resveratrol-3-O-sulfate calibration curve.'' Incorrect values were given on page 329 in the right-hand column of the Results section. The second sentence of the first paragraph should read as follows: ''After consumption of RW and DRW, 24-h urinary excretion of total resveratrol metabolites increased in relation to baseline amounts from 0.94 lmol (95% CI: 0.43, 1.46 lmol) to 6.04 lmol (95% CI: 4.76, 7.31 lmol) and 6.28 lmol (95% CI: 5.10, 7.46 lmol), respectively (P , 0.001, both). Resveratrol metabolite concentrations were not statistically different after DRW and RW interventions (P ¼ 1.00) and were statistically higher after RW and DRW interventions than after gin consumption [0.51 lmol (95% CI: 0.08, 0.94 lmol); P , 0.001]. After the gin intervention, the concentration of resveratrol metabolites did not change significantly compared with that at baseline (P ¼ 1.00).'' Total resveratrol metabolites have been used only as a measure of compliance in this report and were not used in any of the calculations, did not affect the results or discussion of the article, and therefore have no implications for the main results or their interpretation. 
